Labcorp has signed a definitive agreement for the acquisition of select ambulatory outreach laboratory assets from Community Health Systems (CHS) for $195m in cash.
This strategic move will expand Labcorp’s service offerings and provide CHS patients and providers with wider access to advanced testing and laboratory services.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Under the agreement, Labcorp will take over certain patient service centres and in-office phlebotomy locations across 13 US states.
The acquisition adds a comprehensive testing menu, robust data analytics, and digital tools to CHS’ network.
Despite the sale, CHS will retain its inpatient and emergency department laboratories, ensuring continued support for hospital-based services, such as pre-admission testing and imaging.
CHS operations and development executive vice-president Kevin Stockton said: “We are excited about this transaction with Labcorp, which allows us to focus on our core services and improve the overall patient experience, aligning with our unwavering commitment to providing high-quality, accessible healthcare to our communities.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBoth organisations are working to implement a smooth transition that prioritises service continuity for hospitals, patients, clinicians and clients while providing direct access to Labcorp’s additional capabilities.
Labcorp diagnostics president and chief operations officer Mark Schroeder said: “Labcorp and CHS share a deep commitment to improving the health and lives of the communities we serve, and our goal with this agreement is to enhance the patient and provider experience with increased access to high-quality laboratory services.
“This acquisition will allow us to leverage the strengths of both our organisations to positively impact healthcare for communities across the US.”
The transaction, which is subject to regulatory approvals, is expected to close in the fourth quarter of 2025. Until then, CHS assures there will be no operational or service changes.
In April 2025, Labcorp acquired the ambulatory outreach laboratory business of North Mississippi Health Services in the US.
